What does Lion Point Capital, LP hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Lion Point Capital, LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

PRAXIS PRECISION MEDICINES I

$1M4K8.6%

MOONLAKE IMMUNOTHERAPEUTICS

$1M68K7.5%

ROYALTY PHARMA PLC

$1M21K6.1%

MILESTONE PHARMACEUTICALS IN

$975,800820K5.8%

GERON CORP

$861,220578K5.1%

SYNDAX PHARMACEUTICALS INC

$840,96036K5.0%

ARDELYX INC

$770,614129K4.6%

FENNEC PHARMACEUTICALS INC

$691,469112K4.1%

BENITEC BIOPHARMA INC

$660,30062K3.9%

SAREPTA THERAPEUTICS INC

$620,16029K3.7%

Filing history loading…